sameAs
European Vaccine Initiative: lessons from developing malaria vaccinesVaccination for hepatitis C virus: closing in on an evasive targetBCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy controlSmallpox vaccines for biodefense: need and feasibilityYellow fever vaccines and international travelersVaccination of the immunocompromised childDevelopment of a Zika vaccineNovel vaccine development strategies for inducing mucosal immunityHow do natural killer T cells help B cells?Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexAgility in adversity: Vaccines on DemandDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyIssues and challenges in the development of pneumococcal protein vaccinesVaccines for Pseudomonas aeruginosa: a long and winding roadDesigning synthetic vaccines for HIVEbola virus vaccines: an overview of current approachesOntology-supported research on vaccine efficacy, safety and integrative biological networksSalmonella as a vaccine delivery vehicleCurrent advancements and potential strategies in the development of MERS-CoV vaccinesMiddle East respiratory syndrome: obstacles and prospects for vaccine developmentSynthetic DNA vaccine strategies against persistent viral infectionsAdvancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infectionsPrime-boost approaches to tuberculosis vaccine developmentAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesEffect of vaccine administration modality on immunogenicity and efficacy.Current efforts and future prospects in the development of live mycobacteria as vaccinesT-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosisTranscutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchMalaria vaccine based on self-assembling protein nanoparticlesStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Current progress with Moraxella catarrhalis antigens as vaccine candidatesRegulating vaccines at the FDA: development and licensure of Zika vaccines.Tackling a novel lethal virus: a focus on H7N9 vaccine development.Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Improving immunization approaches to cholera.Taking culture seriously in biomedical HIV prevention trials: a meta-synthesis of qualitative studies.The avian influenza vaccine Emerflu. Why did it fail?Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
P1433
Q21032652-0F8A878B-4ABC-4CC7-9315-2E08FD77865CQ22305922-41B4D330-D8ED-4690-9F72-90441B7EFBA7Q22305924-5C1CAA53-330F-4C10-B697-38E44938448DQ22305942-7A66D4EF-3AE8-418E-A43E-3CA90F50E94FQ22305943-70B47CB3-5153-4A70-B8E0-51D6F80052C5Q22305944-2F28AD61-6772-42E0-8634-506E054DA7ADQ24289675-446D21C9-9C29-4C55-B371-BD2A432CC0C0Q24607533-36C46BB2-7621-433F-800C-A7B96C023BE8Q24650966-2DD678F3-664D-4910-8F51-8B92392E83A7Q24737461-CB65BE0F-02B3-4C65-9751-1E79C7822AEBQ26252583-4EFF6AC2-EEE0-4384-A05A-72F539EAEA2EQ26782411-14C8C816-1C66-428B-BD32-47ED7F39D5E0Q26798372-B41080BD-0ECB-4F78-B89C-CD455A4C0C12Q26823701-2CD519BF-C779-4638-8A27-AD2E90C83EB0Q26852817-A05B7038-6375-48D7-9503-A35AEDABDBF9Q26862617-8A91A3B9-0AD4-45A0-B549-A2344E95AA6CQ26999232-3D4EA375-52D9-435B-98E1-6B5C81CB4BA2Q27005991-F755DD7A-4EB0-4DC0-8239-B7AAFC31FA68Q27011946-257A7C4C-1511-4440-90CB-571CE127405FQ27012578-D25DB423-1292-4FC9-BE22-1ADB6EF43A15Q27013314-0C3D75CD-867F-44D5-850B-D20D7236E59EQ27016078-A715538A-A35C-4932-8CD7-79CF56E7B999Q27023470-7888260C-AF8C-493F-8B7B-5202001D01BDQ27024526-4B2CFC81-E922-4D0E-BF5C-9A82202BA3D1Q27024830-77BF507E-ABEF-47D3-8A8D-BC65FBCA9603Q27489000-E220B567-69D8-441F-9C63-4F4177E47514Q27692376-A9B97629-943C-4E67-9E6E-E410572505A8Q28087077-B71CB8DA-E19B-47E2-9947-C79E657489D1Q28155795-F8620E11-0C12-4485-89E6-7C86E86A54CEQ28252883-DC6B5683-4CE3-4FAE-8BE3-10683F2B877EQ28268609-3DFE8B06-DEA0-4A5B-8F3A-442F1F54ADFAQ28299584-F566E9C5-657E-4A2F-98B5-089D8920C0D6Q28304447-2C7D5C5A-FDD8-4622-BADB-1096C9D98A45Q30145676-8111567A-83C1-40F4-BD4B-C9D7FD35D3ABQ30148631-5F833E60-8EC4-40EB-836D-DAC293E5A1C6Q30150784-446E00DB-8B47-414A-B9E2-315766311DA8Q30151668-917E13D7-18D4-4326-86AE-2EB58C9928EEQ30202107-04DD9E8C-F11C-47A3-87A7-D069072F1184Q30203302-32C492B9-492D-4E6D-847A-7B3A010A5F52Q30204348-988B9019-985F-48D2-B346-BD58CA597ED0
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Informa
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Expert Review of Vaccines
@ast
Expert Review of Vaccines
@da
Expert Review of Vaccines
@en
Expert Review of Vaccines
@es
Expert Review of Vaccines
@fi
Expert Review of Vaccines
@fr
Expert Review of Vaccines
@it
Expert Review of Vaccines
@nb
Expert Review of Vaccines
@nl
Expert Review of Vaccines
@nn
type
label
Expert Review of Vaccines
@ast
Expert Review of Vaccines
@da
Expert Review of Vaccines
@en
Expert Review of Vaccines
@es
Expert Review of Vaccines
@fi
Expert Review of Vaccines
@fr
Expert Review of Vaccines
@it
Expert Review of Vaccines
@nb
Expert Review of Vaccines
@nl
Expert Review of Vaccines
@nn
prefLabel
Expert Review of Vaccines
@ast
Expert Review of Vaccines
@da
Expert Review of Vaccines
@en
Expert Review of Vaccines
@es
Expert Review of Vaccines
@fi
Expert Review of Vaccines
@fr
Expert Review of Vaccines
@it
Expert Review of Vaccines
@nb
Expert Review of Vaccines
@nl
Expert Review of Vaccines
@nn
P3181
P4616
P1055
P1058
P1156
P1160
Expert Rev. Vaccines.
P123
P1277
P1476
Expert Review of Vaccines
@en
P236
P3181
P407
P571
2002-01-01T00:00:00Z